Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2022 Sep 3;12(1):15036.
doi: 10.1038/s41598-022-19408-w.

Clinical significance of gastroesophageal reflux disease with minimal change: a multicenter prospective observational study

Affiliations
Observational Study

Clinical significance of gastroesophageal reflux disease with minimal change: a multicenter prospective observational study

Noriaki Manabe et al. Sci Rep. .

Abstract

Non-erosive reflux disease (NERD) is classified into grade N (no minimal change) and grade M (minimal change) based on the Los Angeles classification. However, few reports have described the clinical characteristics of grade M. This study was performed to clarify the clinical characteristics of grade M. Among 290 consecutive patients with gastroesophageal reflux disease (GERD), 45 patients with grade M, 62 patients with grade N, and 94 patients with grade A were compared with respect to clinical differences. The degree of symptom improvement after 4 weeks of proton pump inhibitor administration was also prospectively compared among the three groups. Grades N and M showed no or little difference in the patients' backgrounds (including sex and body mass index), GERD/functional dyspepsia symptom scores, life dissatisfaction (diet, sleep, work, and mood), Short Form-8 (mental component summary) scores, and symptom improvement. In contrast, significant differences were present between grades M and A as well as between grades N and A. The overall results of our study suggest that the distinction between grade M and grade N is of little clinical significance from the viewpoint of clinical characteristics.

PubMed Disclaimer

Conflict of interest statement

This study was funded by GERD Society. KI received honorarium from Takeda Pharmaceutical Industry Company Limited, Otsuka Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd, AstraZeneca K.K. and EA Pharma Co.,Ltd.. KH received honorarium from Takeda Pharmaceutical Company Limited., Astra Zeneca K.K., Otsuka Pharmaceutical Company Limited., and Daiichi Sankyo Company Limited.

Figures

Figure 1
Figure 1
Changes in gastroesophageal reflux disease symptom subscale scores before and after 4 weeks of proton pump inhibitor administration.
Figure 2
Figure 2
Comparison of symptom improvement among the three groups after 4 weeks of proton pump inhibitor administration: Residual rate of gastroesophageal reflux disease symptoms. NOTE: a = analysis of variance, b = Tukey’s honestly significant difference test, d = Cohen’s d.
Figure 3
Figure 3
Comparison of symptom improvement among the three groups after 4 weeks of proton pump inhibitor administration: Symptom improvement through patient impressions. NOTE: a = analysis of variance.
Figure 4
Figure 4
Comparison of symptom improvement among the three groups after 4 weeks of proton pump inhibitor administration: Global assessment scale. NOTE: a = analysis of variance, b = Tukey’s honestly significant difference test, d = Cohen’s d.
Figure 5
Figure 5
Study design.
Figure 6
Figure 6
Typical endoscopic images of LA grades N and M. (a) LA grade N = no endoscopic changes in esophageal mucosa. (b) LA grade M = endoscopic appearance of discoloration of the esophageal mucosa.

Similar articles

References

    1. Manabe N, Haruma K, Kamada T, et al. Changes of upper gastrointestinal symptoms and endoscopic findings in Japan over 25 years. Intern. Med. 2011;50:1357–1363. doi: 10.2169/internalmedicine.50.4731. - DOI - PubMed
    1. Manabe, N., Matsueda, K. & Haruma, K. Epidemiological review of gastroesophageal junction adenocarcinoma in Asian countries. Digestion 1–8 (2021). - PubMed
    1. Pleyer C, Bittner H, Locke GR, 3rd, et al. Overdiagnosis of gastro-esophageal reflux disease and underdiagnosis of functional dyspepsia in a USA community. Neurogastroenterol. Motil. 2014;26:1163–1171. doi: 10.1111/nmo.12377. - DOI - PubMed
    1. Farrell B, Pottie K, Thompson W, et al. Deprescribing proton pump inhibitors: Evidence-based clinical practice guideline. Can. Fam. Physician. 2017;63:354–364. - PMC - PubMed
    1. Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of oesophagitis: Clinical and functional correlates and further validation of the Los Angeles classification. Gut. 1999;45:172–180. doi: 10.1136/gut.45.2.172. - DOI - PMC - PubMed

Publication types

Substances